ANTISENSE GENE-THERAPY DIRECTED AGAINST EBNA-1 IN EBV-ASSOCIATED B-CELL LYMPHOMAS RESULTS IN POTENTIATION OF CHEMOTHERAPY IN-VITRO AND DECREASED TUMOR VIRULENCE IN SCID MICE
Mb. Morgan et al., ANTISENSE GENE-THERAPY DIRECTED AGAINST EBNA-1 IN EBV-ASSOCIATED B-CELL LYMPHOMAS RESULTS IN POTENTIATION OF CHEMOTHERAPY IN-VITRO AND DECREASED TUMOR VIRULENCE IN SCID MICE, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 148-148